FXN and cardiomyopathy: The conditional MCK FXN knockout mouse, targeting cardiac and skeletal muscle, develops pronounced cardiomyopathy and significant weight loss,65 which is likely attributed to the decrease in lean mass due to cardiomyopathy/skeletal muscle dysfunction rather than a decrease in fat mass.